Continuing Medical Education Information

 

AACE Endocrine University

EU Y2 Event Start Date: 11/12/2026
Credit claim deadline: 12/31/2026

 

Statement of Need

Endocrine University® is designed to provide a forum for endocrinology fellows -in-training to enhance their endocrine curriculum, particularly in disease management and practice management skills, which has become essential to the practice of endocrinology.

 

Target Audience

This program is intended for final year endocrine Fellows-in-Training.

 

Learning Objectives

By the end of the meeting, participants will be able to:

  • Effectively utilize new diagnostic technology that has become essential to the practice of endocrinology.
  • Apply the most up-to-date guidelines and evidence-based practices for the diagnosis and treatment of endocrine-related disorders.
  • Integrate the latest evidence-based research for diagnosis and treatment of emerging areas of endocrine-related practice.

 

Accreditation and Designation Statements

ACCME

The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Endocrinology (ACE) designates this other (live virtual) activity for a maximum of 18.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Disclosure and Conflicts of Interest Policy

The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

 

Commercial Supporters

This activity is supported by educational grants from the following:

  • Abbott
  • Corcept Therapeutic
  • Dexcom, Inc.
  • Insulet Corporation
  • Lilly USA, LLC
  • MiniMed (FKA Medtronic)
  • Novartis Pharmaceutical
  • Recordati Rare Diseases
  • Ultragenyx Pharmaceutical
  • Xeris Pharmaceuticals

     

    Planning Committee Disclosures

    Planner Name

    Matthew J. Levine, MD, FACE

    Ineligible Company

    Novo Nordisk
    Ascendis

    Relevant Financial Relationship

    Speakers Bureau
    Speakers Bureau

    Planner Name

    Jayalakshmi Udayasankar

    Ineligible Company

    Dexcom

    Relevant Financial Relationship

    Stock Ownership

    Planner Name

    Helen Lawler

    Ineligible Company

    Amylyx

    Relevant Financial Relationship

    Advisory Board

    All of the relevant financial relationships listed for these individuals have been mitigated. All other planners for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

     

    Faculty Disclosures

    View our faculty disclosures.

    View Faculty Disclosures

     

    Reviewers

    None of the reviewers for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.